{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Eosinophilia, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Eosinophilia, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Eosinophilia, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Eosinophilia, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Anemia, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Anemia, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Anemia, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Anemia, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Hemoglobin increased, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Hemoglobin increased, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Hemoglobin increased, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Hemoglobin increased, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lymphocyte count decreased, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lymphocyte count decreased, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lymphocyte count decreased, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Lymphocyte count decreased, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lymphocyte count increased, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Lymphocyte count increased, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lymphocyte count increased, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Lymphocyte count increased, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Neutrophil count decreased, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Neutrophil count decreased, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Neutrophil count decreased, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Neutrophil count decreased, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"Platelet count decreased, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Platelet count decreased, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}],"title":"Platelet count decreased, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Platelet count decreased, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Leukocytosis, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Leukocytosis, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Leukocytosis, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"Leukocytosis, Increase to Grade 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"White blood cell decreased, Increase to Grade 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"White blood cell decreased, Increase to Grade 2"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}],"title":"White blood cell decreased, Increase to Grade 3"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}],"title":"White blood cell decreased, Increase to Grade 4"}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"}],"units":"Participants"}],"description":"Blood samples were collected for the analysis of following hematology parameters: eosinophils, anemia, hemoglobin increased, lymphocyte count decreased, lymphocyte count increased, neutrophil count decreased, platelet count decreased, leukocytosis and white blood cell decreased. Grade 1 (G1): mild; Grade 2 (G2): moderate; Grade 3 (G3): severe; Grade 4 (G4) life-threatening or disabling. Higher grade indicates greater severity and an increase in CTCAE grade was defined relative to the Baseline grade. Any worst-case post baseline increase to G1, G2, G3, and G4 are presented. The laboratory parameters were graded according to Common Terminology Criteria for Adverse Events (CTCAE) version 5.","groups":[{"description":"Participants with Relapsed/Refractory Multiple Myeloma (RRMM) received 1.9 milligram (mg)/kilogram (kg) belantamab mafodotin intravenous (IV) infusion as powder for solution once every 3 weeks (Q3W) infused over 30- 60 minutes on day 1 of 21-day cycles in combination with 500 mg dostarlimab as a 30-minute IV infusion 1 hour after belantamab mafodotin end of infusion (EOI) on day 1 of 21-day cycles (Q3W).","id":"OG000","title":"1.9 mg/kg Belantamab Mafodotin + 500mg Dostarlimab"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Safety Population.","reportingStatus":"POSTED","timeFrame":"Baseline (Day 1) and up to 153 weeks","title":"DE Phase: Number of Participants With Worst-Case Hematology Results by Maximum Grade Increase Post - Baseline Relative to Baseline","type":"PRIMARY","unitOfMeasure":"Participants"}